CIK: 0001534261 · Show all filings
Period: Q4 2025 (← Previous)
Filing Date: Feb 17, 2026
Total Value ($000): $1,609,916 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| TXG | 10X GENOMICS INC | 1,400,000 | $22,834 | 1.4% | $15.11 | 0.0% | CL A COM | 88025U109 |
| DXCM | DEXCOM INC | 175,000 | $11,615 | 0.7% | $64.65 | 0.0% | COM | 252131107 |
| SRRK | SCHOLAR ROCK HLDG CORP | 260,000 | $11,453 | 0.7% | $37.51 | 0.0% | COM | 80706P103 |
| CI | THE CIGNA GROUP | 40,000 | $11,009 | 0.7% | $279.23 | 0.0% | COM | 125523100 |
| DGX | QUEST DIAGNOSTICS INC | 50,000 | $8,677 | 0.5% | $182.07 | 0.0% | COM | 74834L100 |
| TSHA | TAYSHA GENE THERAPIES INC | 1,500,000 | $8,250 | 0.5% | $4.86 | 0.0% | COM SHS | 877619106 |
| LEGN | LEGEND BIOTECH CORP | 215,000 | $4,674 | 0.3% | $21.74 | — | SPONSORED ADS | 52490G102 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RLAY | RELAY THERAPEUTICS INC | 13,003,574 (+14.7%) | $110,010 (+85.8%) | 6.8% | $15.13 | -52.8% | COM | 75943R102 |
| GH | GUARDANT HEALTH INC | 380,000 (+280.0%) | $38,813 (+521.2%) | 2.4% | $72.99 | +22.6% | COM | 40131M109 |
| ILMN | ILLUMINA INC | 600,000 (+14.3%) | $78,696 (+57.8%) | 4.9% | $116.59 | +0.7% | COM | 452327109 |
| DNLI | DENALI THERAPEUTICS INC | 1,840,000 (+106.7%) | $30,378 (+135.1%) | 1.9% | $22.98 | -26.5% | COM | 24823R105 |
| LAB | STANDARD BIOTOOLS INC | 88,783,856 (+14.5%) | $113,643 (+12.7%) | 7.1% | $2.16 | -37.9% | COM | 34385P108 |
| UNH | UNITEDHEALTH GROUP INC | 50,000 (+100.0%) | $16,506 (+91.2%) | 1.0% | $318.07 | +6.0% | COM | 91324P102 |
| PACB | PACIFIC BIOSCIENCES CALIF IN | 4,223,767 (+483.6%) | $7,898 (+752.6%) | 0.5% | $3.55 | -45.9% | COM | 69404D108 |
| ALNY | ALNYLAM PHARMACEUTICALS INC | 75,000 (+36.4%) | $29,824 (+18.9%) | 1.9% | $219.27 | +101.8% | COM | 02043Q107 |
| HIMS | HIMS & HERS HEALTH INC | 385,000 (+67.4%) | $12,501 (-4.2%) | 0.8% | $40.06 | +6.9% | COM CL A | 433000106 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| EXAS | EXACT SCIENCES CORP | 90,000 | $4,924 | 0.3% | $74.77 | +7.4% | — | 30063P105 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| RVMD | REVOLUTION MEDICINES INC | 2,577,333 (-2.6%) | $205,285 (+66.0%) | 12.8% | $25.89 | +153.2% | COM | 76155X100 |
| GPCR | STRUCTURE THERAPEUTICS INC | 1,175,000 (-24.4%) | $81,721 (+87.7%) | 5.1% | $28.16 | — | SPONSORED ADS | 86366E106 |
| BLFS | BIOLIFE SOLUTIONS INC | 5,957,165 (-11.2%) | $144,044 (-15.8%) | 8.9% | $19.43 | +34.7% | COM NEW | 09062W204 |
| RNA | AVIDITY BIOSCIENCES INC | 1,000,000 (-43.8%) | $72,130 (-7.0%) | 4.5% | $14.11 | +357.9% | COM | 05370A108 |
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| WGS | GENEDX HOLDINGS CORP | 3,007,164 | $391,112 | 24.3% | $9.11 | +1406.1% | COM CL A | 81663L200 |
| MAZE | MAZE THERAPEUTICS INC | 758,857 | $31,439 | 2.0% | $12.04 | +185.5% | COM | 578784100 |
| PRME | PRIME MEDICINE INC | 3,167,175 | $10,990 | 0.7% | $4.73 | -6.0% | COM | 74168J101 |
| TEM | TEMPUS AI INC | 294,127 | $17,368 | 1.1% | $70.04 | +11.7% | CL A | 88023B103 |
| BEAM | BEAM THERAPEUTICS INC | 1,600,000 | $44,352 | 2.8% | $36.48 | -30.1% | COM | 07373V105 |
| SEPN | SEPTERNA INC | 553,268 | $15,425 | 1.0% | $23.65 | +1.0% | COM | 81734D104 |
| NGNE | NEUROGENE INC | 1,295,361 | $26,684 | 1.7% | $27.94 | -10.9% | COM | 64135M105 |
| SPRY | ARS PHARMACEUTICALS INC | 1,600,000 | $18,640 | 1.2% | $14.35 | -32.2% | COM | 82835W108 |
| VCYT | VERACYTE INC | 276,308 | $11,633 | 0.7% | $24.40 | +65.2% | COM | 92337F107 |
| INCY | INCYTE CORP | 100,000 | $9,877 | 0.6% | $79.04 | +22.4% | COM | 45337C102 |
| GLUE | MONTE ROSA THERAPEUTICS INC | 86,014 | $1,349 | 0.1% | $20.37 | -33.8% | COM | 61225M102 |
| IPSC | CENTURY THERAPEUTICS INC | 1,228,190 | $1,222 | 0.1% | $10.97 | -94.4% | COM | 15673T100 |
| ABSI | ABSCI CORPORATION | 973,260 | $3,397 | 0.2% | $19.41 | -81.2% | COM | 00091E109 |
| TNYA | TENAYA THERAPEUTICS INC | 361,969 | $258 | 0.0% | $12.86 | -89.4% | COM | 87990A106 |
| BBOT | BRIDGEBIO ONCOLOGY THERAPEUT | 282,312 | $3,535 | 0.2% | $11.58 | — | COM NEW | 107924102 |
| DNA | GINKGO BIOWORKS HOLDINGS INC | 36,493 | $303 | 0.0% | $10.02 | +7.4% | CL A NEW | 37611X209 |
| RXRX | RECURSION PHARMACEUTICALS IN | 165,323 | $676 | 0.0% | $6.72 | -26.3% | CL A | 75629V104 |
| CTNM | CONTINEUM THERAPEUTICS INC | 148,333 | $1,695 | 0.1% | $16.10 | -29.2% | CL A | 21217B100 |